Ascendis Pharma A/S (ASND)
USD 135.7
(-3.28%)
USD 135.7
(-3.28%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 266.71 Million | 51.17 Million | 7.77 Million | 6.95 Million | 13.37 Million | 10.58 Million |
| Cost of Revenue | 44.39 Million | 12.13 Million | 3.52 Million | - | - | - |
| Gross Profit | 222.32 Million | 39.03 Million | 4.25 Million | 6.95 Million | 13.37 Million | 10.58 Million |
| Operating Expenses | 677.86 Million | 600.85 Million | 456.04 Million | 337.57 Million | 240.09 Million | 165.33 Million |
| Selling, General and Administrative Expenses | 264.41 Million | 221.22 Million | 160.18 Million | 76.66 Million | 48.47 Million | 25.05 Million |
| Research and Development Expenses | 413.45 Million | 379.62 Million | 295.86 Million | 260.9 Million | 191.62 Million | 140.28 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 722.25 Million | 612.98 Million | 459.57 Million | 337.57 Million | 240.09 Million | 165.33 Million |
| Operating Income | -455.54 Million | -561.81 Million | -451.79 Million | -330.62 Million | -226.71 Million | -154.75 Million |
| Interest Expense | 44.06 Million | 50.48 Million | 3.91 Million | 1.91 Million | 1.22 Million | 127 Thousand |
| Income Tax Expense | 7.3 Million | 5.37 Million | -367 Thousand | -219 Thousand | -234 Thousand | -394 Thousand |
| Earnings before Tax | -474.14 Million | -577.81 Million | -383.94 Million | -419.17 Million | -218.25 Million | -130.49 Million |
| Net Income | -481.44 Million | -583.19 Million | -383.57 Million | -418.95 Million | -218.01 Million | -130.09 Million |
| Earnings Per Share Basic | -8.55 | -10.40 | -7.00 | -8.28 | -4.69 | -3.17 |
| Earnings Per Share Diluted | -8.55 | -10.40 | -7.00 | -8.28 | -4.69 | -3.17 |
| Weighted Average Shares Outstanding | 56.28 Million | 56.07 Million | 54.77 Million | 50.61 Million | 46.5 Million | 41.08 Million |
| Weighted Average Shares Outstanding (Diluted) | 56.28 Million | 56.07 Million | 54.77 Million | 50.61 Million | 46.5 Million | 41.08 Million |
| Gross Margin | 0.83 | 0.76 | 0.55 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | -1.64 | -10.30 | -54.47 | -47.30 | -16.23 | -14.19 |
| Profit Margin | -1.81 | -11.40 | -49.32 | -60.26 | -16.30 | -12.30 |
| EBITDA | -438.16 Million | -556.04 Million | -423.66 Million | -328.88 Million | -217.02 Million | -150.17 Million |
| Earnings Before Tax Margin | -1.71 | -10.98 | -58.09 | -47.55 | -16.95 | -14.63 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 36.18 Million | 95.89 Million | 266.71 Million | 137.7 Million | 48.03 Million | 47.39 Million |
| Cost of Revenue | 13.51 Million | 7.56 Million | 44.39 Million | 19.45 Million | 7.38 Million | 12.92 Million |
| Gross Profit | 22.66 Million | 88.32 Million | 222.32 Million | 118.24 Million | 40.64 Million | 34.46 Million |
| Operating Expenses | 156.59 Million | 137.47 Million | 677.86 Million | 154.85 Million | 175.05 Million | 175.3 Million |
| Selling, General and Administrative Expenses | 74.11 Million | 66.78 Million | - | 63.97 Million | 63.61 Million | 70.28 Million |
| Research and Development Expenses | 82.48 Million | 70.68 Million | - | 90.88 Million | 111.43 Million | 105.02 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 170.11 Million | 145.03 Million | 722.25 Million | 174.31 Million | 182.44 Million | 188.23 Million |
| Operating Income | -133.93 Million | -49.14 Million | -455.54 Million | -36.61 Million | -134.4 Million | -140.83 Million |
| Interest Expense | 19.62 Million | 77.16 Million | 44.06 Million | 8.42 Million | 24.51 Million | 9.33 Million |
| Income Tax Expense | -230.15 Thousand | 2.5 Million | 7.3 Million | 5.79 Million | 645 Thousand | -429 Thousand |
| Earnings before Tax | -104.35 Million | -128.52 Million | -474.14 Million | -81.08 Million | -161.57 Million | -121.86 Million |
| Net Income | -109.93 Million | -131.03 Million | -481.44 Million | -86.87 Million | -162.22 Million | -121.43 Million |
| Earnings Per Share Basic | -1.92 | -2.30 | - | -1.53 | -2.88 | -2.16 |
| Earnings Per Share Diluted | -1.92 | -2.30 | - | -1.53 | -2.88 | -2.16 |
| Weighted Average Shares Outstanding | 57.34 Million | 56.88 Million | 56.28 Million | 56.61 Million | 56.27 Million | 56.21 Million |
| Weighted Average Shares Outstanding (Diluted) | 57.34 Million | 56.88 Million | 56.28 Million | 56.61 Million | 56.27 Million | 56.21 Million |
| Gross Margin | 0.63 | 0.92 | 0.83 | 0.86 | 0.85 | 0.73 |
| EBIT Margin | -3.58 | -0.49 | - | -0.49 | -2.75 | -2.28 |
| Profit Margin | -3.04 | -1.37 | -1.81 | -0.63 | -3.38 | -2.56 |
| EBITDA | -129.52 Million | -46.88 Million | - | -67.68 Million | -132.31 Million | -107.88 Million |
| Earnings Before Tax Margin | -3.70 | -0.51 | -1.71 | -0.27 | -2.80 | -2.97 |
0859
LLFICL
ADVM
IFCI
BESTAGRO
INCREDIBLE